Mode
Text Size
Log in / Sign up
N/A N=6 Randomized Basic Science

Short-Term Transcutaneous or Epidural Spinal Stimulation for Enabling Motor Function in Humans With SCI

Paraplegia · Tetraplegia · Paralysis · Quadraplegia

Enrolled (actual)
6
Serious AEs
16.7%
Results posted
Jul 2024
Primary outcome: Primary: Electromyography — 0.00017507; 0.00006740 volts

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Percutaneous epidural electrical spinal stimulation (Device); Transcutaneous electrical spinal stimulation (Device)
Age
Adult, Older Adult · 22+ yrs
Sex
All
Sponsor
Kristin Zhao, PhD
Primary completion
Mar 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Electromyography
0.00017507; 0.00006740
PRIMARY
Foot Pressure
6; 0; 40; 0
PRIMARY
Somatosensory Evoked Potentials
0.67; 0.8; 0.33; 0.35
PRIMARY
Transcranial Magnetic Stimulation Motor Evoked Potentials
3.33; 5
PRIMARY
Injury Severity: International Standards for Neurological Classification of Spinal Cord Injury
0; 0; 0; 0; 0; 0
PRIMARY
Patient-reported Bowel Function
-4; -3.5
PRIMARY
Patient-reported Bladder Function
-11.3; -4.5
PRIMARY
Male Patient-reported Sexual Function (1)
-6.3; 0
PRIMARY
Male Patient-reported Sexual Function (2)
-23.3; -1.5
PRIMARY
Female Patient-reported Sexual Function
PRIMARY
Spasticity
0.057; 0.088
PRIMARY
Neurostimulation User Experience
3; 2.5; 1.5; 1.917; 2.583; 2
PRIMARY
Overground Ambulation [as Appropriate to the Subject]
9.2; 16.5; 16.5
PRIMARY
Trunk Stability
14.933333; 3; 34.933333; 21.5
PRIMARY
Neurostimulator Lead Location and Migration [Epidural Group Only]
-5.35862
PRIMARY
Bladder Function Testing
21; 10.5; 54.666667; 15

Summary

A study comparing short-term delivery of epidural spinal stimulation versus transcutaneous spinal stimulation.

Eligibility Criteria

Inclusion Criteria

  • Spinal cord injury due to trauma located at or above the tenth thoracic vertebrae (T10)
  • American Spinal Injury Association grading scale of A-D (2 from each) below the level of SCI
  • Intact spinal reflexes below the level of SCI
  • At least 1-year post-SCI
  • At least 22 years of age
  • Willing to use medically acceptable methods of contraception, if female and of child-bearing potential

Exclusion Criteria

  • Currently a prison inmate, or awaiting trial, related to criminal activity
  • Pregnancy at the time of enrollment
  • History of chronic and/or treatment resistant urinary tract infection
  • Unhealed decubitus ulcer
  • Unhealed skeletal fracture
  • Untreated clinical diagnosis of depression
  • Undergoing, or planning to undergo, diathermy treatment
  • Active participation in another interventional clinical trial
  • Presence of conditions or disorders which require MRI monitoring
  • A history of coagulopathy or other significant cardiac or medical risk factors for surgery
  • Current use of a ventilator
  • Clinically diagnosed cardiopulmonary complications such as chronic obstructive pulmonary disease, cardiac failure, or heart arrhythmia that contraindicate changes in body position such as supine-to-sit-to-stand activities, prolonged standing, or stepping
  • History of frequent hypotension characterized by light headedness, or loss of consciousness
  • History of frequent hypertension characterized by headache, or bradycardia
  • History of frequent, severe, autonomic dysreflexia
  • Any illness or condition which, based on the research team's assessment, will compromise with the patient's ability to comply with the protocol, patient safety, or the validity of the data collected during this study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05095454). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search